BioPharma Credit (BOPCF) Short Interest Ratio & Short Volume $0.81 0.00 (0.00%) (As of 12/20/2024 ET) Add Share Share Short Interest Stock AnalysisChartShort Interest BioPharma Credit Short Interest DataBioPharma Credit (BOPCF) has a short interest of 100 shares. This marks a -83.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 213,541 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest600 sharesChange Vs. Previous Month-83.33%Dollar Volume Sold Short$87.53Short Interest Ratio1.0 Days to CoverLast Record DateNovember 30, 2024Today's Trading Volume0 sharesAverage Trading Volume213,541 sharesToday's Volume Vs. Average0% Short Selling BioPharma Credit? Sign up to receive the latest short interest report for BioPharma Credit and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBOPCF Short Interest Over TimeBOPCF Days to Cover Over TimeBOPCF Percentage of Float Shorted Over Time Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> BioPharma Credit Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024100 shares $87.53 -83.3%N/A1 $0.88 11/15/2024600 shares $522.60 No ChangeN/A0.2 $0.87 9/15/202411,900 shares $10,710.00 +5,850.0%N/A4.4 $0.90 8/31/2024200 shares $195.00 +100.0%N/A2 $0.98 8/15/2024100 shares $93.00 No ChangeN/A0 $0.93 7/31/2024100 shares $86.20 -97.5%N/A0 $0.86 7/15/20244,000 shares $3,448.00 -92.6%N/A0.8 $0.86 6/30/202454,000 shares $47,023.20 +53,900.0%N/A0.9 $0.87 6/15/2024100 shares $87.08 -50.0%N/A0 $0.87 5/31/2024200 shares $174.16 +100.0%N/A0 $0.87 5/15/2024100 shares $89.00 -50.0%N/A0 $0.89 4/30/2024200 shares $182.16 No ChangeN/A0 $0.91 4/15/2024200 shares $184.00 +100.0%N/A0 $0.92 3/31/2024100 shares $92.00 -50.0%N/A0 $0.92 3/15/2024200 shares $179.88 +100.0%N/A2 $0.90 2/29/2024100 shares $93.10 No ChangeN/A1 $0.93 8/15/20235,000 shares $4,350.00 No ChangeN/A0.1 $0.87 7/31/20235,000 shares $4,350.00 No ChangeN/A0.2 $0.87 BOPCF Short Interest - Frequently Asked Questions What is BioPharma Credit's current short interest? Short interest is the volume of BioPharma Credit shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 100 shares of BOPCF short. Learn More on BioPharma Credit's current short interest. What is a good short interest ratio for BioPharma Credit? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BOPCF shares currently have a short interest ratio of 1.0. Learn More on BioPharma Credit's short interest ratio. Is BioPharma Credit's short interest increasing or decreasing? BioPharma Credit saw a drop in short interest in November. As of November 30th, there was short interest totaling 100 shares, a drop of 83.3% from the previous total of 600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short BioPharma Credit stock? Short selling BOPCF is an investing strategy that aims to generate trading profit from BioPharma Credit as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioPharma Credit? A short squeeze for BioPharma Credit occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BOPCF, which in turn drives the price of the stock up even further. How often is BioPharma Credit's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BOPCF, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BOPCF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.